YAMANOUCHI PHARMA TECHNOLOGIES, INC. – Trademark Portfolio

Entity Type: 03

YAMANOUCHI PHARMA TECHNOLOGIES, INC. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 8 filings in this category. The portfolio also extends into Class 40 (Treatment & Processing) across 3 Nice Classification classes. The owner is based in PALO ALTO, CA.

1050 ARASTRADERO ROAD

PALO ALTO, CA 94304

10 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

WOWTAB
WOWTAB
Cancelled 2001
OCAS
OCAS
Cancelled 2000
WOWTAB
WOWTAB
Cancelled 2000
CODES
CODES
Cancelled 2000
WOWTAB
WOWTAB
Cancelled 1995

Trademark Classifications

YAMANOUCHI PHARMA TECHNOLOGIES, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (8 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

40
Treatment & Processing (4 filings)

Treatment of materials

42
Computer & Scientific (3 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does YAMANOUCHI PHARMA TECHNOLOGIES, INC. have?

YAMANOUCHI PHARMA TECHNOLOGIES, INC. has 10 U.S. trademarks filed with the USPTO.

What trademark classes does YAMANOUCHI PHARMA TECHNOLOGIES, INC. file in?

YAMANOUCHI PHARMA TECHNOLOGIES, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is YAMANOUCHI PHARMA TECHNOLOGIES, INC.'s trademark registration success rate?

YAMANOUCHI PHARMA TECHNOLOGIES, INC. has a 0% trademark registration rate, with 0 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.